A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia

Abstract We report on a novel, successful, non‐cytotoxic therapy to treat multiply‐refractory T‐LGL in an elderly patient.

Bibliographic Details
Main Authors: Misam Zawit, Carmelo Gurnari, Simona Pagliuca, Hassan Awada, Jaroslaw P. Maciejewski, Yogen Saunthararajah
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.4533
_version_ 1819067859429490688
author Misam Zawit
Carmelo Gurnari
Simona Pagliuca
Hassan Awada
Jaroslaw P. Maciejewski
Yogen Saunthararajah
author_facet Misam Zawit
Carmelo Gurnari
Simona Pagliuca
Hassan Awada
Jaroslaw P. Maciejewski
Yogen Saunthararajah
author_sort Misam Zawit
collection DOAJ
description Abstract We report on a novel, successful, non‐cytotoxic therapy to treat multiply‐refractory T‐LGL in an elderly patient.
first_indexed 2024-12-21T16:24:57Z
format Article
id doaj.art-a2d6b592f2254602a5864bbb1284fb37
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-12-21T16:24:57Z
publishDate 2021-09-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-a2d6b592f2254602a5864bbb1284fb372022-12-21T18:57:28ZengWileyClinical Case Reports2050-09042021-09-0199n/an/a10.1002/ccr3.4533A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemiaMisam Zawit0Carmelo Gurnari1Simona Pagliuca2Hassan Awada3Jaroslaw P. Maciejewski4Yogen Saunthararajah5Translational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USATranslational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USATranslational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USATranslational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USATranslational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USATranslational Hematology and Oncology Research Department Taussig Cancer CenterCleveland Clinic Cleveland OH USAAbstract We report on a novel, successful, non‐cytotoxic therapy to treat multiply‐refractory T‐LGL in an elderly patient.https://doi.org/10.1002/ccr3.4533decitabinefrail patientsnon‐cytotoxic regimenT‐cell large granular lymphocytic leukemia
spellingShingle Misam Zawit
Carmelo Gurnari
Simona Pagliuca
Hassan Awada
Jaroslaw P. Maciejewski
Yogen Saunthararajah
A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
Clinical Case Reports
decitabine
frail patients
non‐cytotoxic regimen
T‐cell large granular lymphocytic leukemia
title A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
title_full A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
title_fullStr A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
title_full_unstemmed A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
title_short A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
title_sort non cytotoxic regimen of decitabine to treat refractory t cell large granular lymphocytic leukemia
topic decitabine
frail patients
non‐cytotoxic regimen
T‐cell large granular lymphocytic leukemia
url https://doi.org/10.1002/ccr3.4533
work_keys_str_mv AT misamzawit anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT carmelogurnari anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT simonapagliuca anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT hassanawada anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT jaroslawpmaciejewski anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT yogensaunthararajah anoncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT misamzawit noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT carmelogurnari noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT simonapagliuca noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT hassanawada noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT jaroslawpmaciejewski noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia
AT yogensaunthararajah noncytotoxicregimenofdecitabinetotreatrefractorytcelllargegranularlymphocyticleukemia